Document is current
Any future updates will be listed below
-
Authors
Subbiah, Vivek http://orcid.org/0000-0002-6064-6837
- License Information
-
More Information
Article History
First Online: 9 August 2024
Competing interests
: The author reports no competing interests relevant to this publication, as the content is solely the personal viewpoint of the author. The author reports consulting or advisory roles (paid to institution) from Abbvie, Astex Pharmaceuticals, AstraZeneca, Bayer, Genmab, Incyte, Lilly/Loxo Oncology, Novartis, Obsidian Therapeutics, Pfizer, Pheon Therapeutics, Regeneron, Relay Therapeutics and Roche; and other consulting or advisory roles from Jazz Pharmaceuticals, Incyte, Loxo Oncology /Lilly, Novartis, Relay Therapeutics, Daiichi Sankyo, Illumina and Bayer, and continuing medical education funds from Medscape, OncLive, Clinical Care Communications, PERS and Med Learning Group.
